Family-based behavioural treatment of childhood obesity in a UK National Health Service setting: randomized controlled trial
Author(s)
Type
Journal Article
Abstract
BACKGROUND: The best outcomes for treating childhood obesity have come from comprehensive family-based programmes. However there are questions over their generalizability. OBJECTIVE: To examine the acceptability and effectiveness of 'family-based behavioural treatment' (FBBT) for childhood obesity in an ethnically and socially diverse sample of families in a UK National Health Service (NHS) setting. METHODS: In this parallel group, randomized controlled trial, 72 obese children were randomized to FBBT or a waiting-list control. Primary outcomes were body mass index (BMI) and BMI s.d. scores (SDSs). Secondary outcomes were weight, weight SDSs, height, height SDSs, waist, waist SDSs, FM index, FFM index, blood pressure (BP) and psychosocial measures. The outcomes were assessed at baseline and after treatment, with analyses of 6-month data performed on an intent-to-treat (ITT) basis. Follow-up anthropometric data were collected at 12 months for the treatment group. RESULTS: ITT analyses included all children with baseline data (n=60). There were significant BMI SDS changes (P<0.01) for the treatment and control groups of -0.11 (0.16) and -0.10 (1.6). The treatment group showed a significant reduction in systolic BP (-0.24 (0.7), P<0.05) and improvements in quality of life and eating attitudes (P<0.05), with no significant changes for the control group. However the between-group treatment effects for BMI, body composition, BP and psychosocial outcomes were not significant. There was no overall change in BMI or BMI SDSs from 0-12 months for the treatment group. No adverse effects were reported. CONCLUSIONS: Both treatment and control groups experienced significant reductions in the level of overweight, but with no significant difference between them. There were no significant group differences for any of the secondary outcomes. This trial was registered at http://www.controlled-trials.com/ under ISRCTN 51382628.
Date Issued
2011-09-20
Date Acceptance
2011-08-04
Citation
International Journal of Obesity, 2011, 36 (1), pp.16-26
ISSN
0307-0565
Publisher
Springer Nature [academic journals on nature.com]
Start Page
16
End Page
26
Journal / Book Title
International Journal of Obesity
Volume
36
Issue
1
Copyright Statement
© 2012 Macmillan Publishers Limited All rights reserved. The final publication is available at Springer via https://doi.org/10.1038/ijo.2011.182
Identifier
https://www.nature.com/articles/ijo2011182
Subjects
*Behavior Therapy Blood Pressure *Body Mass Index Child Family Health *Family Therapy Female Humans London/epidemiology Male National Health Programs Obesity/epidemiology/*prevention & control/psychology Pilot Projects *Risk Reduction Behavior Social Adjustment Treatment Outcome Waist Circumference Waiting Lists Weight Loss
Notes
1476-5497 Croker, H Viner, R M Nicholls, D Haroun, D Chadwick, P Edwards, C Wells, J C K Wardle, J A7974/Cancer Research UK/United Kingdom Cancer Research UK/United Kingdom Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't England Int J Obes (Lond). 2012 Jan;36(1):16-26. doi: 10.1038/ijo.2011.182. Epub 2011 Sep 20. BACKGROUND: The best outcomes for treating childhood obesity have come from comprehensive family-based programmes. However there are questions over their generalizability. OBJECTIVE: To examine the acceptability and effectiveness of 'family-based behavioural treatment' (FBBT) for childhood obesity in an ethnically and socially diverse sample of families in a UK National Health Service (NHS) setting. METHODS: In this parallel group, randomized controlled trial, 72 obese children were randomized to FBBT or a waiting-list control. Primary outcomes were body mass index (BMI) and BMI s.d. scores (SDSs). Secondary outcomes were weight, weight SDSs, height, height SDSs, waist, waist SDSs, FM index, FFM index, blood pressure (BP) and psychosocial measures. The outcomes were assessed at baseline and after treatment, with analyses of 6-month data performed on an intent-to-treat (ITT) basis. Follow-up anthropometric data were collected at 12 months for the treatment group. RESULTS: ITT analyses included all children with baseline data (n=60). There were significant BMI SDS changes (P<0.01) for the treatment and control groups of -0.11 (0.16) and -0.10 (1.6). The treatment group showed a significant reduction in systolic BP (-0.24 (0.7), P<0.05) and improvements in quality of life and eating attitudes (P<0.05), with no significant changes for the control group. However the between-group treatment effects for BMI, body composition, BP and psychosocial outcomes were not significant. There was no overall change in BMI or BMI SDSs from 0-12 months for the treatment group. No adverse effects were reported. CONCLUSIONS: Both treatment and control groups experienced significant reductions in the level of overweight, but with no significant difference between them. There were no significant group differences for any of the secondary outcomes. This trial was registered at http://www.controlled-trials.com/ under ISRCTN 51382628.
Publication Status
Published
Date Publish Online
2011-09-20